Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2021 |
|---|
| Accounting Policies [Abstract] |
|
| Summary of Components of Marketable Securities |
Summary
of Components of Marketable Securities
| |
|
As
of June 30, 2021 |
|
| |
|
Amortized |
|
|
Unrealized |
|
|
Fair |
|
| |
|
Cost |
|
|
Losses |
|
|
Value |
|
| U.S.
government obligations |
|
$ |
2,556 |
|
|
$ |
(22 |
) |
|
$ |
2,534 |
|
| Corporate
obligations |
|
|
15,628 |
|
|
|
(67 |
) |
|
|
15,561 |
|
| |
|
$ |
18,184 |
|
|
$ |
(89 |
) |
|
$ |
18,095 |
|
| |
|
As
of December 31, 2020 |
| |
|
Amortized |
|
|
Unrealized |
|
|
Fair |
|
| |
|
Cost |
|
|
Losses |
|
|
Value |
|
| U.S.
government obligations |
|
$ |
1,021 |
|
|
$ |
(7 |
) |
|
$ |
1,014 |
|
| Corporate
obligations |
|
|
629 |
|
|
|
(4 |
) |
|
|
625 |
|
| |
|
$ |
1,650 |
|
|
$ |
(11 |
) |
|
$ |
1,639 |
|
|
| Schedule of Components of Inventory |
Schedule
of Components of Inventory
| |
|
June
30, |
|
|
December
31, |
|
| |
|
2021 |
|
|
2020 |
|
|
Diagnostic
services testing material
|
|
$ |
13,240 |
|
|
$ |
1,028 |
|
| Raw
materials |
|
|
1,249 |
|
|
|
1,404 |
|
| Work
in process |
|
|
345 |
|
|
|
437 |
|
| Finished
goods |
|
|
335 |
|
|
|
170 |
|
| Inventory,
net |
|
$ |
15,169 |
|
|
$ |
3,039 |
|
|
| Schedule of Fair Value of Financial Instruments |
Schedule
of Fair Value of Financial Instruments
| |
|
As
of June 30, 2021 |
|
| |
|
Level
1 |
|
|
Level
2 |
|
|
Level
3 |
|
|
Total |
|
| Marketable
debt securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| U.S.
government obligations |
|
$ |
- |
|
|
$ |
2,534 |
|
|
$ |
- |
|
|
$ |
2,534 |
|
| Corporate
obligations |
|
|
- |
|
|
|
15,561 |
|
|
|
- |
|
|
|
15,561 |
|
| Marketable
equity securities |
|
|
479 |
|
|
|
- |
|
|
|
- |
|
|
|
479 |
|
| |
|
$ |
479 |
|
|
$ |
18,095 |
|
|
$ |
- |
|
|
$ |
18,574 |
|
| |
|
As
of December 31, 2020 |
|
| |
|
Level
1 |
|
|
Level
2 |
|
|
Level
3 |
|
|
Total |
|
| Marketable
debt securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| U.S.
government obligations |
|
$ |
- |
|
|
$ |
1,014 |
|
|
$ |
- |
|
|
$ |
1,014 |
|
| Corporate
obligations |
|
|
- |
|
|
|
625 |
|
|
|
- |
|
|
|
625 |
|
| |
|
$ |
- |
|
|
$ |
1,639 |
|
|
$ |
- |
|
|
$ |
1,639 |
|
|
| Schedule of Deferred Revenue |
Schedule
of Deferred Revenue
| |
|
|
As
of
June 30, 2021 |
|
As
of
December 31, 2020 |
|
| Recognition
Period |
|
|
|
|
|
|
|
|
| 0-12
Months |
|
|
$ |
112 |
|
$ |
169 |
|
| 13-24
Months |
|
|
|
74 |
|
|
84 |
|
| Over
24 Months |
|
|
|
47 |
|
|
78 |
|
| Total |
|
|
$ |
233 |
|
$ |
331 |
|
|
| Schedule of Disaggregation by Revenue |
Schedule
of Disaggregation by Revenue
| |
|
For
the three months ended |
|
|
For
the six months ended |
|
| Revenue
by Customer Type |
|
June
30, 2021 |
|
|
June
30, 2020 |
|
|
June
30, 2021 |
|
|
June
30, 2020 |
|
| Contract
manufacturing |
|
$ |
1,041 |
|
|
$ |
3,472 |
|
|
$ |
2,949 |
|
|
$ |
5,195 |
|
| Retail
and others |
|
|
565 |
|
|
|
151 |
|
|
|
1,190 |
|
|
|
316 |
|
| Diagnostic
services |
|
|
7,536 |
|
|
|
- |
|
|
|
20,274 |
|
|
|
- |
|
| Total
revenue |
|
$ |
9,142 |
|
|
$ |
3,623 |
|
|
$ |
24,413 |
|
|
$ |
5,511 |
|
|